Sign Up Today and Learn More About NephroPlus Stock
Invest in or calculate the value of your shares in NephroPlus or other pre-IPO companies through EquityZen's platform.
NephroPlus Stock (NEPL)
NephroPlus is a dialysis center network that provides dialysis, kidney stone treatment, AV Fistula surgery, and other treatments.
About NephroPlus Stock
Founded
2009
Industries
Software, Artificial Intelligence, Data and Analytics
NephroPlus Press Mentions
Stay in the know about the latest news on NephroPlus
Quadria Capital invests $102M in dialysis chain NephroPlus
yourstory • May 06, 2024
Quadria Capital injects $102 million in NephroPlus; picks up minority stake
tradingview • May 06, 2024
Quadria cap picks up minority stake in NephroPlus
m • May 05, 2024
Bessemer, Investcorp-backed NephroPlus buys Filipino dialysis chain
vccircle • Apr 09, 2024
NephroPlus acquires Philippines dialysis care network RTSI
timesofindia • Apr 09, 2024
NephroPlus Management
Leadership team at NephroPlus
Board of Directors
Subramanya S.V.
Advisory Board
Kelly J. McCrann
Join now and verify your accreditation status to gain access to:
- NephroPlus current valuation
- NephroPlus stock price
- Available deals in NephroPlus and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in NephroPlus stock?
Accredited investors can buy pre-IPO stock in companies like NephroPlus through EquityZen funds. These investments are made available by existing NephroPlus shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NephroPlus stock?
Shareholders can sell their NephroPlus stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."